‘Real-World’ Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey Gregory Y.H. Lip, MD, Cécile Laroche, MSc, Gheorghe-Andrei Dan,

Slides:

Advertisements

Similar presentations

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Advertisements

An Unusual Electrocardiogram in a Heart Transplant Recipient Hamish I. MacLachlan, BSc, MBBS, Jonathan R. Dalzell, MD, MRCP The American Journal of Medicine.

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin k antagonist.

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Severe Tuberculosis Sepsis in an Immunocompetent Patient

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

New-onset Atrial Fibrillation Predicts Heart Failure Progression

A peculiar medical cardioversion of atrial fibrillation with glucose infusion—a rare cause of atrial fibrillation: hypoglycemia Savas Celebi, MD The.

Pneumothorax Recurrence Related to High-speed Lift

Pierre Loulergue, MD, MSc, Agnès Guerre, MD

Renato D. Lopes, MD, PhD, Li Li, MS, Christopher B

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study Torben Bjerregaard Larsen, MD,

An Unusual Cause of Leg Ulcerations

Antithrombotic Treatment Patterns in Patients with Newly Diagnosed Nonvalvular Atrial Fibrillation: The GLORIA-AF Registry, Phase II Menno V. Huisman,

Characteristics of Hospitalized Patients with Atrial Fibrillation in Taiwan: A Nationwide Observation Cheng-Han Lee, MD, Ping-Yen Liu, MD, PhD, Liang-Miin.

Dabigatran and Warfarin for Secondary Prevention of Stroke in Atrial Fibrillation Patients: A Nationwide Cohort Study Torben Bjerregaard Larsen, MD,

Pierre Loulergue, MD, MSc, Agnès Guerre, MD

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Gastric Diverticulum: A Rare Cause of Refractory Epigastric Pain

SAMe-TT2R2 Score, Time in Therapeutic Range, and Outcomes in Anticoagulated Patients with Atrial Fibrillation Pilar Gallego, MD, PhD, Vanessa Roldán,

Thomas E. MacMillan, MD, MSc, Terence Tang, MD, Rodrigo B

Epidemiology of Myelodysplastic Syndromes

Trend in Mortality after Stroke with Atrial Fibrillation

Carotid Sinus Massage in Patients with Suspected Acute Myocardial Infarction, Tachycardia, and Left Bundle Branch Block Teddy Weiss, MD, Yair Elitzur,

Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia

Robert Goulden, MBBS, MSc, MPhil, MA The American Journal of Medicine

Gregory Y.H. Lip, MD, Jonathan L. Halperin, MD, Hung-Fat Tse, MD, PhD

Stuttering Mesenteric Ischemia

Methylene Chloride Intoxication Treated With Hyperbaric Oxygen Therapy

Artificial Hyperparathyroidism—Think Twice Before Taking Your Blood Sample Daniel Foehring, MD, Lars Moeller, MD, Dagmar Fuhrer, MD, Harald Lahner, MD

The Reply The American Journal of Medicine

Jessica L. Lee, MD, MS, Esther S. Oh, MD, Rebecca W. Lee, MD, Thomas E

Gout in African Americans

Carlos Aguilar, MD, Valentin del Villar, MD

Truman J. Milling, MD, Alex C. Spyropoulos, MD

Evaluation of the HAS-BLED, ATRIA, and ORBIT Bleeding Risk Scores in Patients with Atrial Fibrillation Taking Warfarin Keitaro Senoo, MD, Marco Proietti,

Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A

Catheter Ablation for Atrial Fibrillation

Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study Harry J.G.M. Crijns, Bob Weijs, Anna-Meagan.

Fusobacterium nucleatum Bacteremia Presenting with Portal Vein Thrombosis: An Abdominal Lemierre Syndrome? Joseph A. Moore, MD, Siayareh Rambally, MD

The Reply The American Journal of Medicine

Geographic Tongue The American Journal of Medicine

Insomnia in the Elderly: Cause, Approach, and Treatment

Age Differences in Treatment and Control of Hypertension in US Physician Offices, : A Serial Cross-sectional Study Anna Gu, MD, PhD, Yu Yue,

Cluster Syncope The American Journal of Medicine

To Reduce Stroke with PFO Closure, Respect the Shunt

Stroke and Bleeding Risk Co-distribution in Real-world Patients with Atrial Fibrillation: The Euro Heart Survey Maura Marcucci, MD, Gregory Y.H. Lip,

John-Michael Gamble, BScPharm, MSc, Dean T. Eurich, PhD, Thomas J

Trench Mouth The American Journal of Medicine

One-way Versus Two-way Text Messaging on Improving Medication Adherence: Meta- analysis of Randomized Trials David S. Wald, MD, FRCP, Shahena Butt, MSc,

Yoko Miyasaka, MD, PhD, Marion E. Barnes, MSc, Bernard J

Ajay Major, MD, MBA, Mel Anderson, MD The American Journal of Medicine

Purple Urinary Bag Syndrome

National Trends in Ambulatory Oral Anticoagulant Use

A Post-cure Complication

Concomitant Use of Direct Oral Anticoagulants with Antiplatelet Agents and the Risk of Major Bleeding in Patients with Nonvalvular Atrial Fibrillation

Sister Mary Joseph's Node

The American Journal of Medicine

Plasma Lactescence in Acute Pancreatitis

Combining Antiplatelet and Antithrombotic Therapy (Triple Therapy): What Are the Risks and Benefits? Luis Alejandro Asencio, MD, Jennifer J. Huang, DO,

Screening and Treatment of Vitamin D Deficiency on Hospital Admission: Is There a Benefit for Medical Inpatients? Lena Grädel, MD, Meret Merker, BMSc,

Impact of IT-enabled Intervention on MRI Use for Back Pain

Direct Observation of Residents: A Model for an Assessment System

Acquired Generalized Lipodystrophy Following Immune Thrombocytopenia

Falls in Older Adults: Risk Assessment, Management and Prevention

Emily G. McDonald, MD, MSc, Ramy R. Saleh, MD, Todd C. Lee, MD, MPH

Matthew W. Martinez, MD, Keith G. Rasmussen, MD, Paul S

Toward a More Responsible News Media

David Tian, MD, Ram Jhingan Mohan, MD, Gary Stallings, MD

Hypophosphatemia: Diagnostic Significance in Legionnaires’ Disease

Presentation transcript:

‘Real-World’ Antithrombotic Treatment in Atrial Fibrillation: The EORP-AF Pilot Survey Gregory Y.H. Lip, MD, Cécile Laroche, MSc, Gheorghe-Andrei Dan, MD, Massimo Santini, MD, Zbigniew Kalarus, MD, Lars Hvilsted Rasmussen, MD, Popescu Mircea Ioachim, MD, Otilia Tica, MD, Giuseppe Boriani, MD, Paolo Cimaglia, MD, Igor Diemberger, MD, Camilla Fragtrup Hellum, MD, Bettina Mortensen, MD, Aldo P. Maggioni, MD The American Journal of Medicine Volume 127, Issue 6, Pages 519-529.e1 (June 2014) DOI: 10.1016/j.amjmed.2013.12.022 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Antithrombotic drug prescription at inclusion and discharge when the following interventions were performed at the time of the survey or planned at discharge: pharmacologic cardioversion (A), electrical cardioversion (B), or catheter ablation (C). AP = antiplatelet; OAC = oral anticoagulation. The American Journal of Medicine 2014 127, 519-529.e1DOI: (10.1016/j.amjmed.2013.12.022) Copyright © 2014 Elsevier Inc. Terms and Conditions